HBM Partners
Europe, Zug, Switzerland, Zug
Description
HBM Partners was founded in 2001 with the goal to invest in private and public emerging biopharma and other healthcare-related companies.
Investor Profile
HBM Partners has made 55 investments, with 0 in the past 12 months and 15% as lead.
Stage Focus
- Series B (24%)
- Series C (18%)
- Series Unknown (18%)
- Convertible Note (13%)
- Series A (11%)
- Series D (7%)
- Private Equity (5%)
- Series E (2%)
- Debt Financing (2%)
Country Focus
- United States (62%)
- Germany (13%)
- Switzerland (7%)
- Colombia (4%)
- Japan (4%)
- Canada (4%)
- Italy (4%)
- Austria (2%)
- The Netherlands (2%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Pharmaceutical
- Therapeutics
- Medical Device
- Health Diagnostics
- Biopharma
- Oncology
- Women's
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
